At Phenomic, we are pioneers in using advanced machine learning tools for processing imaging, RNA sequencing, and spatial transcriptomics data to understand the biology of single-cells sitting in complex multi-cell systems. We are first movers in targeting the tumor stroma. We anticipate that armed with a powerful platform for generating and analyzing complex multi-cell systems, we will be at the forefront of the next wave of stroma targeted medicines. By then identifying optimal settings for combining these stromal targeted therapies with existing medicines we hope to improve patient outcomes in some of the most difficult to treat cancers.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2017
- Website
- phenomic.ai/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Phenomic AI?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now